G(M2) Ganglioside

Clinical trial pipeline · Data from ClinicalTrials.gov

See which G(M2) Ganglioside trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

WithdrawnPhase 1

NCT00679744

A Phase I Study of Pyrimethamine in Patients With GM2 Gangliosidosis

Adult Tay-Sachs disease and Sandhoff diseases are caused by deficiency of an enzyme called β-hexosaminidase A, or Hex A in short. This enzyme is located in a pa…

United States, Canada0Started 2008-05

Treatment: Pyrimethamine